Skip to main content

Animations

MJFF Publications

3651 - 3660 of 6456 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2020
  • 2020
  • 2021
  • 2020
  • 2020
  • 2021
  • 2020
  • 2019
  • Summary Details
    OPEN
    Title: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00702-019-02125-6
    Citation Count: 21
  • Summary Details
    OPEN
    Title: The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-019-02066-0
    Citation Count: 105
  • Summary Details
    OPEN
    Title: Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime Sleepiness
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2019.01353
    Citation Count: 18
  • Summary Details
    OPEN
    Title: mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s disease
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-019-0214-x
    Citation Count: 115
  • Summary Details
    OPEN
    Title: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00162-1
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Extracellular clusterin limits the uptake of α‐synuclein fibrils by murine and human astrocytes
    Journal Name: Glia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/glia.23920
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20200930
    Citation Count: 46
  • Summary Details
    OPEN
    Title: A protease protection assay for the detection of internalized alpha-synuclein pre-formed fibrils
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0241161
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000010863
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awz350
    Citation Count: 243
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.